Vir Biotechnology Inc
VIR
Market Cap$1.06B
Close$
$12.26
160.8% upside
Current Fair Value
160.8% upsideUndervalued by 160.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.06 Billion |
|---|---|
| Enterprise Value | $945.19 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-4.59 |
| Beta | 0.46 |
| Outstanding Shares | 136,233,725 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.18 |
|---|---|
| PEG | -7.09 |
| Price to Sales | - |
| Price to Book Ratio | 0.59 |
| Enterprise Value to Revenue | 12.02 |
| Enterprise Value to EBIT | -1.73 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Vir Biotechnology Inc
327 employeesVir Biotechnology is a clinical-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are desi...